Labcorp Holdings Inc (LH) Stock News

Rosen Law Firm has filed a securities class action lawsuit against Celsius Holdings, Inc. (CELH) on behalf of investors who purchased securities between February 21, 2025 and June 3, 2026. The lawsuit alleges that Celsius made materially false and misleading statements regarding the cardiac risks of its Alani Nu products and inappropriately marketed these products to consumers under 18 years old. The lead plaintiff deadline is November 3, 2026.

A securities fraud investigation into Alignment Healthcare continues following allegations that a former executive filed a whistleblower lawsuit claiming the company manipulated finances by misclassifying operating expenses as capital expenditures to artificially inflate adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the disclosure.

The Rosen Law Firm has issued notices regarding class action securities lawsuits against three companies: Celsius Holdings (CELH) for allegedly failing to disclose health risks associated with its energy drink products and marketing to minors; Taboola.com (TBLA) with an October 20 deadline; and XTI Aerospace (XTIA) with an October 27 deadline. Investors who suffered losses exceeding $100,000 are urged to seek legal counsel.

Robbins LLP is reminding investors about a class action lawsuit against Celsius Holdings (CELH) for allegedly misleading investors about the safety of Alani Nu energy drinks marketed to teenagers. The lawsuit covers the period from February 21, 2025 to June 3, 2026. The case was triggered by reports of a 17-year-old's death linked to the high-caffeine drinks and a subsequent investigation by the Texas Attorney General. The stock fell significantly following these revelations.

A whistleblower lawsuit alleges that Alignment Healthcare manipulated its finances by misclassifying $8-10 million in operating expenses as capital expenditures to artificially inflate adjusted EBITDA and report false positive earnings. The stock fell 16.7% on the news, injuring investors.

Alignment Healthcare's stock plummeted 59% between July and October 2026 after CMS downgraded its California HMO plan (H3815) from 4.0 to 3.5 Star Rating, making it ineligible for quality bonus payments. The company faces investor scrutiny over allegedly misleading statements about its confidence in maintaining bonus eligibility, with management refusing to discuss Star Rating positioning in September before the downgrade was publicly disclosed.

Celsius Holdings (CELH) is trending but faces headwinds. The stock has underperformed the S&P 500 over the past month (+1.1% vs +2.1%). While revenue growth is solid at +26.6% for the current fiscal year, earnings estimates have declined over the past month, and the company received a Zacks Rank #4 (Sell) rating. The stock trades at a premium valuation (Grade D) and is expected to underperform the broader market in the near term.

Norwegian Cruise Line (NCLH) declined 1.41% on October 12, 2026, underperforming the broader market. The company faces headwinds with expected EPS declining 26.67% quarter-over-quarter and 26.07% year-over-year, while revenue is projected to decline 2.13% quarterly. NCLH holds a Zacks Rank of #5 (Strong Sell) with downward estimate revisions over the past month, though it trades at a valuation discount to its industry peers.

Rosen Law Firm has filed class action lawsuits on behalf of investors in Celsius Holdings, Inc. and other companies. The Celsius lawsuit alleges that the company made materially false and misleading statements regarding cardiac risks associated with Alani Nu products and inappropriately marketed these products to consumers under 18. Investors who purchased securities during the specified class periods may be eligible for compensation. The deadline to serve as lead plaintiff is November 3, 2026.

A class action lawsuit has been filed against Celsius Holdings (CELH) for allegedly making false and misleading statements about the safety of Alani Nu energy drinks, which contain 200mg of caffeine per 12oz serving. The complaint alleges the company marketed high-caffeine products to consumers under 18 despite known cardiac risks, following a wrongful death lawsuit involving a 17-year-old and a Texas Attorney General investigation. The stock fell significantly on news of the investigation.

Rosen Law Firm has filed class action lawsuits against Celsius Holdings, Inc. and other companies on behalf of investors who purchased securities during specified periods. The Celsius lawsuit alleges that the company made materially false and misleading statements regarding cardiac risks associated with Alani Nu products and inappropriately marketed these products to consumers under 18. Investors who purchased Celsius securities between February 21, 2025 and June 3, 2026 may be eligible for compensation. The deadline to serve as lead plaintiff is November 3, 2026.

Norwegian Cruise Line (NCLH) fell 1.78% to $14.87, underperforming broader market gains. The stock has declined 2.76% over the past month. Upcoming earnings are projected to show a 26.67% year-over-year EPS decline to $0.88 per share, with revenue expected to drop 2.13%. NCLH holds a Zacks Rank of #5 (Strong Sell) with a Forward P/E of 9.73, trading at a discount to its industry average of 15.17.

Rosen Law Firm has filed a class action lawsuit against Celsius Holdings, Inc. (CELH) on behalf of investors who purchased securities between February 21, 2025 and June 3, 2026. The lawsuit alleges that Celsius made materially false and misleading statements regarding cardiac risks associated with its Alani Nu products and inappropriately marketed these products to consumers under 18 years old. The firm is seeking lead plaintiffs with a deadline of November 3, 2026.

Norwegian Cruise Line Holdings (NCLH) has attracted significant investor attention but faces headwinds. The stock has declined 5.8% over the past month, underperforming the S&P 500. Earnings estimates for the current fiscal year show a -26.1% year-over-year decline, though next year is expected to grow 7.9%. The company received a Zacks Rank #5 (Strong Sell) rating, suggesting near-term underperformance relative to the broader market, despite trading at a valuation discount to peers.

Clean Harbors (CLH) is highlighted as an attractive growth stock with a Zacks Rank #2 (Buy) and Growth Score of B. The environmental services company demonstrates strong fundamentals including projected EPS growth of 33.6% (vs. 10.3% industry average), efficient asset utilization with an S/TA ratio of 0.82 (vs. 0.54 industry average), and positive earnings estimate revisions. Sales are expected to grow 7.7% this year compared to the industry average of 4.5%.

A class action lawsuit was filed against Celsius Holdings (CELH) for allegedly misleading investors about the safety of its Alani Nu energy drinks for teenagers. The drinks contain 200mg of caffeine, double the recommended daily limit for ages 12-17. The lawsuit was triggered after a 17-year-old Texas cheerleader's death was linked to the product and the Texas Attorney General launched an investigation into marketing practices targeting minors. CELH stock fell significantly following these revelations in April and June 2026.

Celsius Holdings Inc. (CELH) closed at $28.02, down 1.13% while the S&P 500 gained 0.17%. The stock has declined 12.91% over the past month, underperforming the Consumer Staples sector. The company holds a Zacks Rank of #5 (Strong Sell) with recent EPS estimates revised 0.55% lower. While revenue is expected to grow 11.23% next quarter and 26.6% for the full year, EPS is forecasted to decline 16.67% quarterly. The stock trades at a Forward P/E of 19.6, above its industry average of 14.06.

Celsius Holdings Inc. (CELH) gained 2.22% to $27.22, outperforming the S&P 500's 0.86% gain on September 11, 2026. However, the stock has declined 7.47% over the past month. The company is forecasted to report an EPS of $0.35 (down 16.67% year-over-year) with revenue projected at $806.54 million (up 11.23% year-over-year). CELH currently holds a Zacks Rank #5 (Strong Sell) rating with a Forward P/E of 18.35, trading at a premium to its industry average.

In a comparison of two Retail - Home Furnishings stocks, Alliance Laundry Holdings (ALH) emerges as the superior value option over Williams-Sonoma (WSM). ALH holds a Zacks Rank of #2 (Buy) with stronger earnings outlook improvements, a lower forward P/E ratio of 15.78 versus WSM's 23.54, and a better Value grade of B compared to WSM's D. ALH's PEG ratio of 0.92 and P/B ratio of 8.35 also indicate better valuation metrics than WSM's 2.40 and 12.31 respectively.

Pomerantz Law Firm is investigating L3Harris Technologies for potential securities fraud following the immediate resignation of Chairman and CEO Christopher Kubasik on August 17, 2026, due to conduct inconsistent with company values. The announcement triggered a 4.61% stock price decline, falling $13.44 per share to $278.38.

While Wall Street analysts maintain a bullish average brokerage recommendation (ABR) of 1.59 for Celsius Holdings with 16 Strong Buy ratings, the article cautions that brokerage recommendations often have positive bias due to vested interests. The Zacks Rank system, which relies on earnings estimate revisions, rates CELH as a Strong Sell (#5) due to a 7.5% decline in consensus earnings estimates over the past month to $1.47, suggesting near-term downside risk.

Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) for potential securities violations following a whistleblower complaint alleging accounting irregularities and misclassification of operating expenses as capital expenditures. The allegations artificially inflated the company's financial results and Adjusted EBITDA metrics. ALHC stock fell 16.7% on July 8, 2026, following the news.

Law firm Lowey Dannenberg is investigating Alignment Healthcare (ALHC) for potential federal securities violations following allegations by a former executive that the company manipulated finances by misclassifying $8-10 million in operating expenses as capital expenditures to artificially inflate adjusted EBITDA. The disclosure caused Alignment's stock to fall 16.7% on July 8, 2026.

Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) following a whistleblower complaint alleging accounting irregularities where millions in operating expenses were misclassified as capital expenditures, artificially inflating financial metrics including Adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the disclosure.

Hagens Berman is investigating Alignment Healthcare, Inc. (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to artificially inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

Law firm Kaplan Fox is investigating Alignment Healthcare for alleged accounting irregularities where millions in operating expenses were misclassified as capital expenditures, artificially inflating financial metrics including Adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the whistleblower complaint disclosure.

Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to inflate EBITDA and financial results for 2024-2025. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities, misclassifying operating expenses as capital expenditures to inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

Block & Leviton is investigating Alignment Healthcare, Inc. (ALHC) for potential securities law violations following allegations that a former executive filed a whistleblower lawsuit claiming the company manipulated finances to boost stock price and executive compensation. The stock fell approximately 16.72% following the report. The firm is also investigating Jefferies Financial Group and Unicycive Therapeutics for similar violations.

Law firm Johnson Fistel announced an investigation into Alignment Healthcare (NASDAQ: ALHC) following a whistleblower lawsuit filed by a former executive alleging the company manipulated its finances to boost stock price and executive compensation. The firm is investigating whether the company complied with federal securities laws and is seeking investors who suffered losses.